Last updated: 26 August 2024 at 8:12pm EST

Dr. Paul K. Audhya M.B.A., M.D. Net Worth




The estimated Net Worth of Paul K. Audhya is at least $921 mil dollars as of 22 August 2024. Dr Audhya owns over 5,000 units of KalVista Pharmaceuticals Inc stock worth over $920,634 and over the last 3 years he sold KALV stock worth over $0.

Dr D KALV stock SEC Form 4 insiders trading

Dr has made over 10 trades of the KalVista Pharmaceuticals Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 5,000 units of KALV stock worth $53,600 on 22 August 2024.

The largest trade he's ever made was exercising 30,614 units of KalVista Pharmaceuticals Inc stock on 17 May 2024 worth over $328,182. On average, Dr trades about 9,967 units every 53 days since 2021. As of 22 August 2024 he still owns at least 85,880 units of KalVista Pharmaceuticals Inc stock.

You can see the complete history of Dr Audhya stock trades at the bottom of the page.





Dr. Paul K. Audhya M.B.A., M.D. biography

Dr. Paul K. Audhya M.B.A., M.D. is the Chief Medical Officer at KalVista Pharmaceuticals Inc.



What's Dr D's mailing address?

Paul's mailing address filed with the SEC is C/O KALVISTA PHARMACEUTICALS, INC., 55 CAMBRIDGE PARKWAY, SUITE 901E, CAMBRIDGE, MA, 02142.

Insiders trading at KalVista Pharmaceuticals Inc

Over the last 8 years, insiders at KalVista Pharmaceuticals Inc have traded over $74,823,944 worth of KalVista Pharmaceuticals Inc stock and bought 4,877,063 units worth $58,591,487 . The most active insiders traders include Holdings A/S Novo, Capital Management, L.P.Ra ... y Rajeev M. Shah. On average, KalVista Pharmaceuticals Inc executives and independent directors trade stock every 19 days with the average trade being worth of $835,088. The most recent stock trade was executed by Benjamin L Palleiko on 6 September 2024, trading 15,625 units of KALV stock currently worth $167,500.



What does KalVista Pharmaceuticals Inc do?

kalvista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.



What does KalVista Pharmaceuticals Inc's logo look like?

KalVista Pharmaceuticals Inc logo

Complete history of Dr Audhya stock trades at KalVista Pharmaceuticals Inc

Fecha
#
Empresa
Persona
Trans.
Transacción
Acciones Precio por acción Precio total Acciones después de Fuente
22 Aug 2024 Paul K. Audhya
CHIEF MEDICAL OFFICER
Uso de opción 5,000 $12.42 $62,100
22 Aug 2024
85,880
17 Aug 2024 Paul K. Audhya
CHIEF MEDICAL OFFICER
Uso de opción 18,528 $12.00 $222,336
17 Aug 2024
88,853
17 May 2024 Paul K. Audhya
CHIEF MEDICAL OFFICER
Uso de opción 30,614 $11.92 $364,919
17 May 2024
83,500
17 Feb 2024 Paul K. Audhya
CHIEF MEDICAL OFFICER
Uso de opción 30,613 $14.86 $454,909
17 Feb 2024
67,181
17 Nov 2023 Paul K. Audhya
CHIEF MEDICAL OFFICER
Uso de opción 18,530 $8.12 $150,464
17 Nov 2023
44,553
17 Aug 2023 Paul K. Audhya
CHIEF MEDICAL OFFICER
Uso de opción 18,529 $10.93 $202,522
17 Aug 2023
34,043
17 Feb 2023 Paul K. Audhya
CHIEF MEDICAL OFFICER
Uso de opción 6,446 $8.12 $52,342
17 Feb 2023
6,313
11 Jan 2023 Paul K. Audhya
CHIEF MEDICAL OFFICER
Uso de opción 6,447 $6.82 $43,969
11 Jan 2023
15,794
17 Nov 2022 Paul K. Audhya
CHIEF MEDICAL OFFICER
Uso de opción 2,419 $5.37 $12,990
17 Nov 2022
6,668
17 Aug 2022 Paul K. Audhya
CHIEF MEDICAL OFFICER
Uso de opción 2,418 $15.21 $36,778
17 Aug 2022
2,418


KalVista Pharmaceuticals Inc executives and stock owners

KalVista Pharmaceuticals Inc executives and other stock owners filed with the SEC include: